Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day+100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?

Medeni S. S., Acar C., Olgun A., Acar A., Seyhanli A., Taskiran E., ...More

CLINICAL TRANSPLANTATION, vol.32, no.9, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 32 Issue: 9
  • Publication Date: 2018
  • Doi Number: 10.1111/ctr.13359
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Keywords: Monocyte Lymphocyte Ratio (MLR), Multiple myeloma, Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), POOR-PROGNOSIS, INFLAMMATION, CANCER, MICROENVIRONMENT, SURVIVAL, IMPROVES, AGENTS, INDEX
  • Dokuz Eylül University Affiliated: Yes


Background: Recent reports have showed that neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR) are predictors of progression-free survival (PFS) and overall survival (OS) in many types of cancer. This study evaluates the predictive value of NLR, MLR, and PLR for survival in MM patients treated with to ASCT.